1 member of Congress have disclosed 1 trade in Lineage Cell Therapeutics, Inc. (LCTX) since 2024: 0 purchases worth about $0.00 and 1 sale worth about $8.00K. The most active was Anna Paulina Luna, with 1 trade. The latest trade was made on Jan 2, 2024.
LCTX’s price and SPY’s, both as the change since the start of the range. A green triangle marks a day members bought LCTX, a red one a day they sold; hover for who and how much.
| # | Member | Trades | Buys | Sells | Bought (est.) | Sold (est.) | Net | Buys vs SPY | First Traded | Last Traded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Anna Paulina LunaR-FL | 1 | 0 | 1 | $0.00 | $8.00K | -$8.00K | – | Jan 2, 2024 | Jan 2, 2024 |
| Owner | Type | Filing | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Anna Paulina LunaR-FL | LCTXLIneage Cell Therapeutics inc | Self | Sell | $1K–$15K | Jan 2, 2024 | Jan 29, 2024 | 27d | -7.3% | -66.5% |
Tip. Hover a row for the filing’s full asset text and comments; the PDF link opens the report itself.
1 member of Congress have disclosed 1 trade in Lineage Cell Therapeutics, Inc. (LCTX) since 2024: 0 purchases worth about $0.00 and 1 sale worth about $8.00K. The most active was Anna Paulina Luna, with 1 trade. The latest trade was made on Jan 2, 2024. Most active: Anna Paulina Luna (1).
Since 2024 they have disclosed 0 purchases and 1 sale; by the midpoints of the disclosed ranges, about $0.00 bought and $8.00K sold, a net sale of $8.00K.
Members of Congress report each trade over $1,000 within 45 days under the STOCK Act, with the amount as a range. The chart marks the days members traded LCTX on its price, against the S&P 500 over the same days.
Members of Congress disclose trades as dollar ranges, up to 45 days after the trade and sometimes later. Volumes use the midpoints of those ranges and are estimates; portfolio figures are a model built from the disclosed trades, not the members’ actual accounts. Not investment advice.